Ensuring Effective Oversight of Delegated Clinical Trial Tasks

Delegating trial-related tasks to a CRO or specialty vendor is standard practice, and ICH E6(R3) explicitly accommodates it  but delegation of the task is not delegation of the oversight responsibility. The guidance is specific that sponsors need to be able to demonstrate they maintained appropriate oversight of delegated activities, not just that a qualified vendor was selected. Here are six things that expectation actually requires in practice.

1. A documented basis for the delegation decision itself

Choosing a CRO or vendor should be traceable to a documented evaluation of their qualifications and capability for the specific delegated task not just a general vendor relationship extended to cover new responsibilities without a fresh, specific assessment.

2. Ongoing monitoring of delegated task performance, not just initial qualification

Oversight doesn't end once a vendor is selected and onboarded. Sponsors need an ongoing mechanism for monitoring whether delegated tasks are actually being performed to the expected standard throughout the relationship, not just at the point of initial selection.

3. Visibility into the vendor's own quality and compliance practices

A sponsor delegating a task still needs meaningful visibility into how the vendor performing it maintains quality and compliance — not full operational control, but enough transparency to identify a developing issue before it becomes a significant finding.

4. Clear escalation pathways when a delegated task isn't meeting expectations

When a vendor's performance on a delegated task falls short, there needs to be a defined escalation process that leads to a documented resolution — not an informal conversation with no clear record of what was identified and how it was addressed.

5. A defensible audit trail connecting sponsor oversight activity to vendor performance

An inspector examining a delegated relationship isn't just checking whether the vendor did the work correctly — they're checking whether the sponsor can demonstrate active oversight of that work throughout the relationship, with a clear record connecting the two.

6. Periodic reassessment of whether the delegation remains appropriate

A delegation that made sense at study start may need reassessment as a study evolves — increased complexity, expanded scope, or performance issues may warrant revisiting whether the original delegation decision still holds. Sponsors need a mechanism for this periodic reassessment, not a one-time decision treated as permanent.

What separates adequate from inadequate oversight of delegated tasks

Why this matters for multi vendor, multi CRO study models

As sponsors increasingly rely on specialty vendors and functional service providers alongside full-service CROs, the number of delegated relationships requiring this kind of demonstrable oversight grows. A sponsor managing several delegated relationships simultaneously needs a systematic approach to this oversight, not an ad hoc process repeated differently for each vendor.

How Cloudbyz supports this

Cloudbyz's connected platform gives sponsors visibility into operational and quality data across CTMS, eTMF, EDC, and Safety modules, which is designed to support the kind of ongoing oversight ICH E6(R3) expects even when specific tasks are performed by a delegated vendor working within the same connected system. Audit trails capture activity across the platform, supporting a sponsor's ability to demonstrate oversight alongside vendor performance.

See how Cloudbyz supports demonstrable sponsor oversight of delegated tasks — book a demo with your own vendor and CRO relationships in mind.